CORT•prnewswire•
CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm
Summary
SAN FRANCISCO, Jan. 21, 2026 /PRNewswire/ -- Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter ("CRL") from the FDA for its proposed treatment of...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 21, 2026 by prnewswire